NCT01250730 - A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Healthy

Interventions

DRUG

PF-02341066

Cohort 1: a 150 mg single dose of PF-02341066 administered as 1 x 50 mg IRT and 1 x 100 mg IRT.

DRUG

PF-02341066

Cohort 2: a 250 mg single dose of PF-02341066 administered as 1 x 50 mg IRT and 2 x 100 mg IRTs.

DRUG

PF-02341066

Cohort 3: a 400 mg single dose of PF-02341066 administered as 4 x 100 mg IRTs.

Trial Locations (1)

Pfizer Investigational Site, Hachioji-shi